You have no items in your shopping cart.
0item(s)
You have no items in your shopping cart.
In the evolving landscape of longevity science, researchers are increasingly moving away from broad-spectrum "anti-ageing" claims toward more targeted metabolic interventions. Two compounds have emerged as primary points of interest for those investigating cellular health and metabolic efficiency: NAD+ and AOD9604.
While often grouped together under the umbrella of "longevity peptides," these two substances operate via fundamentally different pathways. NAD+ acts as a critical coenzyme for cellular energy and repair, while AOD9604 is a synthetic peptide fragment designed to modulate lipid metabolism. Understanding the distinction between these two, and how they might work in tandem, is essential for any rigorous research protocol.
At AXIOM Health, we prioritize precision. Whether you are investigating mitochondrial decay or adipocyte metabolism, choosing the right compound requires a deep dive into the underlying mechanisms. In this guide, we will compare NAD+ research peptides and AOD9604 research to help you structure your next study with clarity.
NAD+ (Nicotinamide Adenine Dinucleotide) is perhaps the most critical molecule in the field of longevity research. Unlike AOD9604, which is a synthetic peptide, NAD+ is a naturally occurring coenzyme found in every living cell. It is the primary electron carrier in the redox reactions that drive the Krebs cycle and oxidative phosphorylation.
The interest in NAD+ research stems largely from its role as a necessary substrate for sirtuins (SIRT1-7). These "longevity genes" are responsible for regulating cellular homeostasis, mitochondrial biogenesis, and DNA repair. As we age, systemic NAD+ levels naturally decline, leading to a decrease in sirtuin activity and a subsequent rise in genomic instability.
Researchers focusing on longevity often look at how exogenous NAD+ or its precursors can "refuel" these pathways. By maintaining adequate levels, cells can more effectively engage PARPs (Poly ADP-ribose polymerases), the enzymes responsible for repairing single-strand DNA breaks.

When you are designing a protocol around NAD+, your primary focus is typically on:
For those interested in foundational cellular health, our NAD+ 500mg vials provide a high-purity platform for exploring these vital biological pathways.
While NAD+ provides the "fuel" for cellular repair, AOD9604 (Anti-Obesity Drug 9604) is a more specialized tool. It is a synthetic C-terminal fragment of human growth hormone (HGH), specifically amino acids 176–191.
The primary goal of AOD9604 research is to isolate the lipolytic (fat-burning) properties of HGH without the associated anabolic effects. This is a critical distinction for researchers; while full-spectrum HGH can cause insulin resistance and elevated IGF-1 levels, AOD9604 appears to avoid these pitfalls entirely.
AOD9604 works through a dual-action mechanism in adipose tissue:

For longevity researchers, AOD9604 is particularly interesting because metabolic health is a prerequisite for lifespan extension. Excess visceral fat is a major driver of metabolic syndrome and cardiovascular decline. By researching a compound that targets fat metabolism without disrupting blood glucose, you can investigate more refined pathways for improving body composition and metabolic resilience.
When you are deciding between these two compounds for your study, it helps to view them through the lens of their primary function.
| Feature | NAD+ | AOD9604 |
|---|---|---|
| Classification | Coenzyme / Small Molecule | Synthetic Peptide Fragment (HGH 176-191) |
| Primary Target | Sirtuins, Mitochondria, DNA | Adipose Tissue (Fat Cells) |
| Main Mechanism | ATP production & Cellular Repair | Lipolysis & Lipogenesis Inhibition |
| Growth Factors | No effect on IGF-1 | No effect on IGF-1 |
| Study Focus | Biological Age, Energy, Longevity | Body Composition, Metabolic Health |
If your research goal is to understand how to slow the aging process at a fundamental, cellular level, NAD+ is the clear choice. However, if you are focusing on the metabolic consequences of obesity and visceral fat, and how these factors accelerate aging, AOD9604 offers a more targeted approach.
In the research community, it is becoming increasingly common to see these two compounds used in conjunction. We often refer to this as a "top-down and bottom-up" approach to metabolic optimization.
NAD+ provides the mitochondrial efficiency needed to oxidize the fatty acids that AOD9604 releases into the system. Without sufficient NAD+, the increased lipolysis triggered by AOD9604 may be less effective, as the mitochondria lack the "machinery" to process that liberated energy efficiently.
This synergy is why we have developed the Cellular Fundamentals Stack. By combining NAD+, AOD9604, and KPV (a potent anti-inflammatory peptide), researchers can study a comprehensive protocol that addresses repair, metabolism, and inflammation simultaneously.

When conducting research with high-purity compounds, the method of handling is just as important as the compound itself. Please ensure you follow established lab protocols for reconstitution and storage to maintain the stability of your research materials.
Whether you are investigating the systemic benefits of NAD+ or the targeted metabolic effects of AOD9604, the key to success is clarity of intent. NAD+ serves as the essential bedrock of cellular life, while AOD9604 provides a specialized scalpel for metabolic refinement.
We invite you to explore our full range of research-grade peptides to find the compounds that best fit your specific study objectives. By focusing on high-purity, protocol-driven research, we can continue to push the boundaries of what is possible in longevity science.
Please don't hesitate to reach out if you have questions regarding the technical specifications of our products. We are here to support your research journey with the precision and transparency you require.